冠状动脉旁路移植术与经皮冠状动脉介入治疗后6个月的生存质量对比研究

付春; 秦俊超; 赵舟; 陈彧; 韩增强; 安友仲; 赵连泽

doi:10.13201/j.issn.1001-1439.2021.08.008

冠状动脉旁路移植术与经皮冠状动脉介入治疗后6个月的生存质量对比研究

- 1. 北京大学人民医院重症医学科(北京, 100044);
- 2. 北京大学人民医院心脏中心心脏外科;
- 3. 上海中医药大学附属曙光医院创伤科
基金项目:
北京大学人民医院研究与发展基金(科研)(No:RDY2019-32)

详细信息

通讯作者: 赵舟,E-mail:zhaozhou8@126.com

中图分类号: R541.4

收稿日期: 2021-02-03

Comparative study on the quality of life after 6months of coronary artery bypass grafting and percutaneous coronary intervention

- 1. Department of Critical Care Unit, Heart Center, People's Hospital of Peking University, Beijing, 100044, China;
- 2. Department of Cardiac Surgery, Heart Center, People's Hospital of Peking University;
- 3. Department of Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

More Information

Corresponding author: ZHAO Zhou, E-mail: zhaozhou8@126.com

Received Date: 03 February 2021

摘要

摘要: 目的:对比冠状动脉旁路移植术(CABG)及经皮冠状动脉介入(PCI)治疗后的冠心病患者术后6个月生存质量的改善情况。方法:对2018年6月—2019年6月符合纳入标准的连续297例接受CABG的患者及169例接受PCI(药物洗脱支架)的患者发放SF-36 QoL量表并对患者进行生存质量评估。比较两组患者术前及术后6个月生存质量改善情况。结果:除躯体疼痛和总体健康维度外,PCI组在术前其他各维度评分中均显著高于CABG组(P<0.05);两组患者术后6个月时在所有维度中的生存质量分值均较术前显著提高(均P<0.05);术后6个月CABG组仅总体健康维度优于PCI组(P<0.05);采用协方差分析校准CABG组和PCI组的组间差异后再次比较显示,相较于PCI组,CABG组术后6个月显示出更好的生存质量改善的趋势,尽管结果尚无明显统计学意义。结论:QoL量表有助于定量分析CABG及PCI术后患者的生存质量;从长远来看,CABG在患者远期生存质量方面更具优势。
- 生存质量 /
- 冠状动脉旁路移植术 /
- 冠状动脉介入
Abstract: Objective: To compare the improvement of quality of life between percutaneous coronary intervention(PCI) and coronary artery bypass grafting(CABG) after 6 months.Methods: From June 2018 to June 2019, 297 consecutive patients with CABG and 169 patients with PCI(drug-eluting stent) who met the inclusion criteria were given SF-36 QoL scale, and their quality of life was evaluated. The improvement of quality of life before and 6 months after operation was compared between the two groups.Results: Except for the physical pain and overall health dimensions, PCI group was significantly higher than CABG group in all other dimensions before operation(P < 0.05); The quality of life score in all dimensions after 6 months was significantly higher than that before operation(P < 0.05); The total health dimension of CABG group was better than PCI group(P < 0.05); After adjusting the difference between CABG group and PCI group by covariance analysis, the results showed that compared with PCI group, the quality of life in CABG group improved better after 6 months, although the results were not statistically significant.Conclusion: QoL scale is helpful to analyze the quality of life after CABG and PCI. In the long run, CABG has more advantages in patients' long-term quality of life.
- quality of life /
- coronary artery bypass grafting /
- percutaneous coronary intervention

HTML全文

参考文献(16)

[1]	Spadaccio C,Benedetto U.Coronary artery bypass grafting(CABG)vs.percutaneous coronary intervention(PCI)in the treatment of multivessel coronary disease:quo vadis?-a review of the evidences on coronary artery disease[J].Ann Cardiothorac Surg,2018,7(4):506-515.
[2]	Barile JP,Horner-Johnson W,Krahn G,et al.Measurement characteristics for two health-related quality of life measures in older adults:The SF-36 and the CDC Healthy Days items[J].Disabil Health J,2016,9(4):567-574.
[3]	冯杰莉,李昭屏,张喆,等.冠状动脉旁路移植术后远期左乳内动脉桥血管血流储备影响因素分析[J].临床心血管病杂志,2020,36(6):565-569.
[4]	Raja SG,Ilsley C,De Robertis F,et al.Mid-to-long term mortality following surgical versus percutaneous coronary revascularization stratified according to stent subtype:An analysis of 6,682 patients with multivessel disease[J].PLoS One,2018,13(2):e0191554.
[5]	Ozaki Y,Katagiri Y,Onuma Y,et al.CVIT expert consensus document on primary percutaneous coronary intervention(PCI)for acute myocardial infarction(AMI)in 2018[J].Cardiovasc Interv Ther,2018,33(2):178-203.
[6]	Lu Y,Zhang H,Wang Y,et al.Percutaneous coronary intervention in patients without acute myocardial infarction in China:Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention[J].JAMA Netw Open,2018,1(8):e185446.
[7]	吕俊兴,许海燕,杨跃进,等.中国急性心肌梗死患者住院时间及其延长的影响因素分析[J].临床心血管病杂志,2020,36(10):890-894.
[8]	Cronin EM,Bogun FM,Maury P,et al.2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias[J].J Interv Card Electrophysiol,2020,59(1):145-298.
[9]	Kral BG,Kalyani RR,Yanek LR,et al.Relation of plasma lipoprotein(a)to subclinical coronary plaque volumes,three-vessel and left main coronary disease,and severe coronary stenoses in apparently healthy african-americans with a family history of early-onset coronary artery disease[J].Am J Cardiol,2016,118(5):656-661.
[10]	Kataruka A,Maynard CC,Kearney KE,et al.Temporal trends in percutaneous coronary intervention and coronary artery bypass grafting:insights from the Washington cardiac care outcomes assessment program[J].J Am Heart Assoc,2020,9(11):e015317.
[11]	Luc J,Choi JH,Rizvi SA,et al.Percutaneous coronary intervention versus coronary artery bypass grafting in heart transplant recipients with coronary allograft vasculopathy:a systematic review and meta-analysis of 1,520 patients[J].Ann Cardiothorac Surg,2018,7(1):19-30.
[12]	Fanari Z,Weiss SA,Zhang W,et al.Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease:Meta-analysis of six randomized controlled trials[J].Cardiovasc Revasc Med,2015,16(2):70-77.
[13]	Jian Z,Tjabc D,Yhabc D,et al.Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease:A systematic review and meta-analysis-ScienceDirect[J].Atherosclerosis,2020,308(9):50-56.
[14]	Zheng JF,Zheng JL,Lou XY,et al.TCTAP A-017long-term outcomes of percutaneous coronary intervention versus coronary artery bypass surgery in elderly patients with multivessel and/or left main coronary artery disease and diabetes mellitus:a systematic review and meta-analysis[J].J Am Coll Cardiol,2021,77(14):S12-13.
[15]	Huber A,Oldridge N,H9fer S.International SF-36reference values in patients with ischemic heart disease[J].Qual Life Res,2016,25(11):2787-2798.
[16]	Nilsson E,Festin K,Lowén M,et al.SF-36predicts 13-year CHD incidence in a middle-aged Swedish general population[J].Qual Life Res,2020,29(4):971-975.